Birch Capital Management, LLC Embecta Corp. Transaction History

Birch Capital Management, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 11, 2023	SELL	$15.0 - $22.17 $360 - $532	-24 Reduced 8.96%	244 $3,000
Q2 2023 Jul 12, 2023	SELL	$21.6 - $30.69 $950 - $1,350	-44 Reduced 14.1%	268 $5,000
Q1 2023 Apr 10, 2023	SELL	$23.07 - $32.77 $92 - $131	-4 Reduced 1.27%	312 $8,000
Q4 2022 Feb 06, 2023	SELL	$25.29 - $35.48 $4,602 - $6,457	-182 Reduced 36.55%	316 $7,000
Q3 2022 Mar 30, 2023	BUY	$24.0 - $33.42 $4,368 - $6,082	182 Added 57.59%	498 $14,000
Q3 2022 Oct 06, 2022	SELL	$24.0 - $33.42 $26,952 - $37,530	-1,123 Reduced 69.28%	498 $14,000
Q2 2022 Mar 30, 2023	BUY	$24.78 - $33.36 $32,337 - $43,534	1,305 Added 412.97%	1,621 $41,000
Q2 2022 Jul 07, 2022	BUY	$24.78 - $33.36 $40,168 - $54,076	1,621 New	1,621 $41,000

405

51.1M

162K

61K

Ticker EMBC
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 57,836,500
Market Cap $1.17B
Description
Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes. The company primarily sells its products to whole...

Get notified when there are updates to the investment portfolio of Birch Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Birch Capital Management, LLC with notifications on news.